Medicine
Jeuveau 100 units powder
Jeuveau 100 units powder is a prescription medicine containing Botulinum toxin type a for intramuscular use, marketed by Evolus, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Unopened vials of JEUVEAU should be stored in a refrigerator between 2° to 8°C…
Key facts
- Active ingredient (INN)
- Botulinum toxin type a
- Brand
- Jeuveau
- Strength
- 100 units
- Dosage form
- Powder
- Route
- Intramuscular
- Packs
- 1 vial
- Marketing authorisation holder
- Evolus
- Manufacturer
- Evolus
- Origin register
- US FDA, United States
- Storage
- Unopened vials of JEUVEAU should be stored in a refrigerator between 2° to 8°C (36° to 46° F) in the original carton to protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 February 2019
- Identifiers
- RxCUI 2117871, 2117876DailyMed set ID 17a914c1-e54b-4b50-965d-b0fd9111bba4NDC 72301-595Application BLA761085
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 1 powder in 1 vial | 72301-595-10 | Evolus | 13 February 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Botulinum toxin type a
Clinical summary
Botulinum toxin type a is an acetylcholine release inhibitor indicated for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/ or procerus muscle activity in adult patients. MedsAcross supplies Botulinum toxin type a for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Botulinum toxin type aFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DAXXIFY prescribing information (Revance Therapeutics) · U.S. National Library of Medicine, DailyMed
Need Jeuveau 100 units powder for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.